The potential universality of the miR-221-3p/LIFR pathway is underscored by pan-cancer evidence showing consistent miR-221-3p upregulation and inversely correlated LIFR expression across malignancies (Fig. 7B), with functional roles established in hepatocellular and gastric carcinomas [48, 55]. Here, LIFR is linked to cancer.